Disability rights and experiential use of psychedelics in clinical research and practice.
npj Mental Health Research July 2, 2024 Maryam Golafshani, Daniel Z. Buchman, Muhammad Ishrat Husain 3 citations
Given the renewed interest in the use of psychedelics for the treatment of mental and substance use disorders in recent decades, there has also been renewed discussion and debate about whether it is necessary or beneficial for those who study and deliver psychedelic-assisted psychotherapy (PAP) to have had personal experience of using psychedelics. This paper provides a brief history of this...